# CALQUENCE

NDC: 0310-3512
Generic name: acalabrutinib
Labeler / Manufacturer: AstraZeneca Pharmaceuticals LP
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20220804

FDA application: NDA216387

## Active ingredients

- ACALABRUTINIB: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0310-3512"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0310-3512
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1409184-3267-4d8c-8f17-4e01f69828b1